Share Reporting Publications Events & Calendar Bonds & Rating Contact & Service Reporting Q4/FY 2024 Evonik has published its FY/Q4 2024 report on March 5, 2025. You can access further information here. Evonik with new Group structure Evonik is putting in place a new segment structure and adopting a significantly leaner management model. Here you'll find further information and downloads, like a video message from Christian Kullmann (CEO) and Maike Schuh (CFO) Presentations Here you'll find all current IR presentations: Roadshow presentation Factbook Innovation@EvonikSustainability@Evonik CMD & other Events Investor Relations News March 05, 2025 Investor Relations Evonik clearly beats previous year’s results and aims for further growth Evonik posted a strong increase in operating profit in 2024. Adjusted EBITDA rose 25 percent to €2.065 billion, within the guided range of €1.9 billion to 2.2 billion. February 25, 2025 Investor Relations Green hydrogen economy: Evonik is building a plant for anion exchange membranes Evonik baut in Marl eine Pilotanlage zur Produktion ihrer innovativen und leistungsfähigen Anionen-Austausch-Membran (AEM). January 08, 2025 Investor Relations Evonik successfully issues third green bond Evonik Industries AG successfully issued a green bond today December 13, 2024 Investor Relations Leaner and more differentiated: Evonik with new Group structure Evonik is putting in place a new segment structure and adopting a significantly leaner management model. The company’s business lines, which so far have been bundled into four divisions, will now be led directly by members of the Executive Board. November 06, 2024 Investor Relations Successful third quarter during economic crisis In the third quarter, Evonik again earned significantly more than in the same period of the previous year. Between July and September, adjusted EBITDA rose 19 percent to €577 million. As a result, the specialty chemicals company - as forecast – reached the earnings level of the second quarter (€578 million). October 11, 2024 Investor Relations Evonik aligns two business lines with new growth strategy Evonik is reorganizing two business lines to strengthen their growth prospects. Coating & Adhesive Resins and Health Care will focus on and concentrate future investments in their respective core businesses. View all Events Quarterly Report Q1 2025 Online - On-demand Online 05/12/2025 Annual Shareholders‘ Meeting 2025 Online - Live Online 05/28/2025 Quarterly Report Q2 2025 Online - On-demand Online 08/01/2025 Quarterly Report Q3 2025 Online - On-demand Online 11/04/2025
:16-9-X-Large "Title of the image")
